SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Crucell N.V. (CRXL) -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (142)1/7/2004 1:31:52 PM
From: nigel bates  Respond to of 560
 
impressive for a 'mere' cell line/production method for a conventional flu shot, albeit one with clear advantages.

Shows how significant the advantages might be.

And, one hopes, funds your Italian jaunt as well. <g>



To: keokalani'nui who wrote (142)1/7/2004 8:38:38 PM
From: Madharry  Respond to of 560
 
thanks to both you and nigel for bringing this one to my attention.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News